December 12, 2024 16:59 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess | Devendra Fadnavis meets PM Modi amid suspense over Maharashtra portfolio allocation | Congress wants to deviate the issue of Sonia Gandhi-George Soros link: JP Nadda | Bengaluru techie suicide: Atul Subhash's family demanded Rs. 10 lakh as dowry leading to my father's death, claims estranged wife | Syria rebels torch tomb of ousted president Bashar al-Assad's father | Donald Trump vows to eliminate birthright citizenship after taking charge | No alliance with Congress in Delhi polls: AAP chief Arvind Kejriwal | Bengaluru techie's suicide: Atul Subhash's wife and her family booked | Bengaluru techie's suicide: Atul Subhash's wife and her family booked
Kotak AMC's Pharma portfolio outperforms benchmark Nifty in 1-3 year period

Kotak AMC's Pharma portfolio outperforms benchmark Nifty in 1-3 year period

Nov 13, 2020, at 10:17 pm

Kolkata: Kotak Mahindra Asset Management Company Limited’s (KMAMC) Portfolio Management Service division (Kotak PMS), today announced that it will share profits with investors generated from the Kotak Pharma and Healthcare (Kotak Pharma) portfolio. Pharma and healthcare stocks have become market darlings.